Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
54,639,404
-
Share change
-
-9,508,217
-
Total reported value
-
$38,905,281
-
Put/Call ratio
-
0%
-
Price per share
-
$0.71
-
Number of holders
-
54
-
Value change
-
-$8,718,148
-
Number of buys
-
16
-
Number of sells
-
34
Institutional Holders of ORCHARD THERAPEUTICS PLC - ADS (ORTX) as of Q1 2022
As of 31 Mar 2022,
ORCHARD THERAPEUTICS PLC - ADS (ORTX) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,639,404 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., FMR LLC, FEDERATED HERMES, INC., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Artisan Partners Limited Partnership, CHI Advisors LLC, Artal Group S.A., JPMORGAN CHASE & CO, SG Americas Securities, LLC, and Temasek Holdings (Private) Ltd.
This page lists
54
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.